Weiguo Liu

Appearances

Integration of high throughput experimentation (HTE) capabilities in a hit-to-lead drug discovery program accelerated the discovery of glucosylceramide synthase inhibitors (GCSi) for the treatment Parkinson’s disease | Poster Board #3464
Date
August 21, 2022
Our research laboratories have invested in high throughput experimentation (HTE) capabilities as a method of research design to more rapidly and efficiently progress drug discovery and development…
Presenter
Nancy Kevin
Speakers
Shawn Walsh
Yuriy Slutskyy
Tiffany Piou
Weiguo Liu
Zheng Tan
Yan Guo
Zhongxiang Sun
Dong Xiao
Melissa Ford
Anthony Donofrio
Cyndi He
Ling Tong
Santhosh Neelamkavil
Rob Mazzola
Merck
Mark Fraley